cabozantinib
exelixis
['bladder', 'cabozantinib', 'gu ']
day 1 of #asco22 off to an exciting start. insightful discussion on adjuvant therapies in gu malignancies, cabozantinib in bladder cancer, depth of response as a bio marker of survival, and so much more ! 
GU Medical Oncologist. Clinical investigator. Cleveland Clinic alum. Views my own.